Peak6 LLC Gh Research PLC Transaction History
Peak6 LLC
- $45.9 Billion
- Q4 2024
A detailed history of Peak6 LLC transactions in Gh Research PLC stock. As of the latest transaction made, Peak6 LLC holds 1,100 shares of GHRS stock, worth $15,741. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,100Holding current value
$15,741% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GHRS
# of Institutions
34Shares Held
28.3MCall Options Held
10.3KPut Options Held
3.7K-
Bvf Inc San Francisco, CA10.4MShares$149 Million2.72% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.69MShares$95.7 Million0.76% of portfolio
-
Lynx1 Capital Management LP San Juan, PR4.86MShares$69.5 Million13.21% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$47.6 Million0.38% of portfolio
-
Verition Fund Management LLC Greenwich, CT918KShares$13.1 Million0.03% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $744M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...